Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |